Pretreatment HIV‐1 Drug Resistance Among Newly Diagnosed People in Eastern Ethiopia
Background and Aims In Ethiopia, HIV‐1 pretreatment drug resistance (PDR) data are limited owing to a lack of routine genotyping resistance tests. This study aimed to determine the prevalence of HIV‐1 PDR mutations and genetic diversity among newly ...
Abdella Gemechu +8 more
doaj +4 more sources
Impact of HIV Pretreatment Drug Resistance on Secondary Transmission Through Treatment Dropout: A Prospective Population-Based Study in Southwestern China [PDF]
Yi Chen,1,* Xiaoshan Xu,2,* Huanhuan Chen,3,* Xiangjun Zhang,4 Qiuying Zhu,3 Shujia Liang,3 Hui Xing,2 Lingjie Liao,2 Yi Feng,2 Yiming Shao,2 Yuhua Ruan,2 Guanghua Lan,3 Jianjun Li3 1The Guangxi Academy of Medical Sciences, The ...
Chen Y +12 more
doaj +4 more sources
Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China. [PDF]
AbstractObjectivesThe emergence of pretreatment drug resistance (PDR) caused by increased usage of antiretroviral therapy (ART) represents a significant challenge to HIV management. In this study, we evaluated the prevalence of PDR in people living with HIV (PLWH) in Chongqing, China.MethodsWe retrospectively collected the data of 1110 ART‐naïve PLWH ...
Liu M +10 more
europepmc +4 more sources
HIV-1 genetic diversity and pretreatment drug resistance survey prior to dolutegravir introduction in Senegal. [PDF]
This study aimed to document the prevalence of pretreatment drug resistance in antiretroviral therapy-naïve patients in Senegal, describe mutation profiles, and evaluate their potential impact on future therapy.A pretreatment drug resistance survey was carried out in 35 sites throughout the country between 2017 and 2018 using dried blood spots and ...
Fall M +11 more
europepmc +4 more sources
Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017 [PDF]
Background After the scale-up of antiretroviral therapy (ART) for HIV infected people, increasing numbers of patients have pretreatment drug resistance (PDR).
Rui-Hua Kang +16 more
doaj +3 more sources
Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China [PDF]
Background Genetic variability and liability to develop drug-resistant mutations are the main characteristics of HIV-1, which can not only increase the risk of antiretroviral treatment (ART) failure, but also can lead to the spread of resistant strains ...
Zhenyan Wang +6 more
doaj +2 more sources
A Sensitivity and Consistency Comparison Between Next-Generation Sequencing and Sanger Sequencing in HIV-1 Pretreatment Drug Resistance Testing [PDF]
Next-generation sequencing (NGS) for HIV drug resistance (DR) testing has an increasing number of applications for the detection of low-abundance drug-resistant variants (LA-DRVs) in regard to its features as a quasi-species.
Ying Zhou +6 more
doaj +2 more sources
Cost-effectiveness of pretreatment HIV drug resistance testing in people living with HIV in Iran.
IntroductionHIV drug resistance (HIVDR) is an important challenge in the fight against HIV/AIDS and can threaten progress toward achieving the target of HIV elimination by 2030. Genotyping pretreatment HIVDR testing (DRT) has been proposed as a potential
Hossein Mirzaei +6 more
doaj +3 more sources
Disparity of HIV-1 Pretreatment Drug Resistance in Men Who Have Sex With Men and the Heterosexual Population in Guangxi, China. [PDF]
Pang X +10 more
europepmc +2 more sources
Characterization of sexually acquired HIV-1 transmission networks and genetic variation in northern frontier China, 2021–2024 [PDF]
BackgroundIn Baotou, sexual transmission is the primary route of HIV-1 infection among newly reported cases. Given the increasing prevalence in recent years, this study aimed to identify the factors driving local viral spread and analyze the ...
Yu Liu +16 more
doaj +2 more sources

